Tamtam Try Tamtam free
Cedars-Sinai logo

Cedars-Sinai account plan

Leading healthcare, research, education

At a glance

Cedars-Sinai is a Los Angeles nonprofit academic health system with three hospital groups and $8,586,547 thousand of FY2025 revenues.

Cedars-Sinai Health System is a California nonprofit, tax-exempt academic health system and the sole corporate member of Cedars-Sinai Medical Center, Torrance Memorial and Huntington Hospital in the Los Angeles area, providing patient care, medical research, health education and community service. Commercial and managed care is by far its largest payer class. In FY2025 (year ended June 30, 2025) total revenues, gains and other support were $8,586,547 thousand and income from operations fell to $238,931 thousand, while investment income lifted the excess of revenues over expenses to $852,165 thousand. It runs one of the 10 largest hospital-based research programs in America; Dr. Peter Slavin is president and CEO.

Business units

Strategic priorities

Accelerating Excellence programme
A top-to-bottom initiative to "grow revenue, reduce expenses, and come up with a game plan with respect to those headwinds before they hit".
Operating efficiency and access
More efficient operating rooms, shorter hospital stays and wider access to outpatient locations.
Philanthropy growth
Grow the philanthropic programme, which the CEO says has grown significantly but has "significantly more potential".
Commercialising research
Commercialise intellectual property from one of the 10 largest hospital-based research programs in America, including co-creating digital health companies with Redesign Health.
Digital care and international presence
Virtual platforms CS Link and CS Connect, ambient documentation for physicians and inpatient nurses, and a first flagship outpatient clinic outside the U.S. in London with Guy's and St Thomas'.

Investments and deals

Facilities capital programme
Expenditures for property and equipment of $657,770 thousand in FY2025, up from $474,013 thousand, with construction-in-progress reaching $1,065,249 thousand, mostly buildings.
Software and cloud systems
Gross property includes $1,141,200 thousand of software and software implementation costs, and the system capitalises cloud hosting implementation costs.
Providence Tarzana joint venture
49% interest in Tarzana Medical Center, LLC with Providence St. Joseph Health; capital contributions totalled $335,228 thousand at June 30, 2025.
London clinic
First clinical presence outside the U.S., a flagship outpatient clinic in London run in partnership with Guy's and St Thomas'.

Challenges and risks

Payer mix deterioration
The CEO expects patients covered by government programs to become uninsured as enhanced ACA tax credits expired and Medicaid cuts under HR1 unfold, with "a significant impact on our finances".
Costs rising faster than revenue
Total expenses rose to $8,347,616 thousand in FY2025, with salaries and related costs of $4,161,181 thousand, cutting income from operations from $328,909 thousand to $238,931 thousand.
Research funding uncertainty
The CEO sees "some wobble in Washington, D.C., around enthusiasm for supporting biomedical research".
Litigation
Wage-and-hour class actions and PAGA claims, and 2024 litigation against an obstetrics and gynecology physician and Cedars-Sinai Medical Center that "may have a material impact on Cedars-Sinai's financial position".

What leadership says

“We don't want to wait until we're underwater and have to do some desperate things.”

Dr. Peter Slavin, President and CEO · Chief Healthcare Executive interview ahead of ViVE 2026, February 11, 2026

“We're trying to grow our philanthropic program. It's grown significantly in recent years, but we think there's significantly more potential to turn to philanthropists and ask them to support our mission”

Dr. Peter Slavin, President and CEO · Chief Healthcare Executive interview ahead of ViVE 2026, February 11, 2026

“We are rolling out ambient documentation for physicians, and something similar for inpatient nurses, so they can reduce documentation time and spend more time with patients.”

Dr. Peter L. Slavin, President and CEO · Investment Reports interview (undated)

Where a supplier can help

Operating room and length-of-stay efficiency
The Accelerating Excellence levers on OR efficiency and shorter stays create demand for capacity management, patient flow and perioperative analytics.
Clinical documentation AI
The rollout of ambient documentation for physicians and inpatient nurses opens room for AI documentation and workflow vendors that cut clinician time.
Outpatient and virtual access
Wider outpatient access and the CS Link and CS Connect platforms point to needs in scheduling, virtual care and patient access tools.
Construction and facilities
Construction-in-progress of $1,065,249 thousand at June 30, 2025, mostly buildings, tied to the facilities capital programme, suits construction, medical equipment and facilities-management suppliers.
Revenue cycle under payer pressure
With payer mix expected to worsen, revenue cycle, eligibility and cost-reduction services address a stated challenge.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Cedars-Sinai?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Cedars-Sinai

What is Cedars-Sinai?

Cedars-Sinai Health System is a Los Angeles nonprofit academic health system made up of Cedars-Sinai Medical Center, Torrance Memorial and Huntington Hospital, with a large research programme.

What is Cedars-Sinai's revenue?

Total revenues, gains and other support were $8,586,547 thousand in FY2025 (year ended June 30, 2025), of which net patient service revenues were $7,415,712 thousand.

Who leads Cedars-Sinai?

Dr. Peter Slavin, formerly at Mass General, is president and CEO.

What is Cedars-Sinai's strategy?

Its Accelerating Excellence initiative aims to grow revenue and reduce expenses ahead of Medicaid and ACA headwinds, through operating efficiency, outpatient access, philanthropy and research commercialisation.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)